A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT)

Low Dosage Computerized Tomography (LDCT) has been shown to improve early detection of lung cancer and mortality rates in high-risk individuals, which was, however, limited by specifically coverage for heavy smokers and high rates of false positivity. Here, we aim to investigate a novel biomarker fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaobing, Zhi, Xiuyi, Yang, Zhaogang, Tian, Haimei, Li, Yanfen, Li, Mo, Zhao, Wenya, Zhang, Chao, Wang, Teng, Liu, Jing, Shen, Di, Zheng, Cuining, Zhao, Dan, Yang, Sheng, Qi, Jun, Xin, Hongwu, Stojadinovic, Alexander, Avital, Itzhak, Lee, L. James, Rao, Jianyu, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542191/
https://www.ncbi.nlm.nih.gov/pubmed/28514755
http://dx.doi.org/10.18632/oncotarget.17477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542191/
https://www.ncbi.nlm.nih.gov/pubmed/28514755
http://dx.doi.org/10.18632/oncotarget.17477

Ejemplares similares